An intracellular staining procedure for the cytoskeletal marker, glial fibrillary acidic protein of astrocytes, has been developed which allows flow cytometric phenotyping of astrocytes within complex mixttires of glial cells. Employing this technique, we show here that measles virus infection of rat mixed gl.ial cell cultures results in a rapid augmentation of major histocompatibility complex (MHC) dass I and ICAM-1 on the majority of astrocytes in culture. MHC class I Ievels are increased on macrophages/microglia but ICAM-1 expression is not normally affected on this cell type. Some MHC dass II induction is also observed after virus infection but only on astrocytes. A type-I interferon (IFN)-inducible protein, Mx, was identified in cultured glial cells after infection. Qualitatively comparable MHC dass I and ICAM-1 enhancement after addition of type-I IFN, supports the conclusion that this cytokine(s) releasedas a result ofvirus infection, is responsible for alterations in the expression of molecules on glial cells, that are involved in T cell recognition. Astrocytes after viral infection were more susceptible to alloantigen-specific cytotoxic T lymphocytes and cytotoxic T lymphocyte activity was substantially reduced in the presence of mAb specific for MHC class I, ICAM-1 and LFA-1 but not MHC dass II. The relevance of these findings toT cell recognition of virus-infected cells in the centrat nervaus system is discussed.
Introduction
Measles virus (MV) is a common human pathogen responsible for a range of diseases from acute MV infection of childhood through to severe infections of the central nervous system (CNS). Within this Iatter category, disease types vary from acute measles encephalitis to subacute sclerosing panencephalitis in which onset of clinical disease generally occurs many years after recovery from normal acute MV infection (reviewed in [1] ). An effective immunological response to such infections of the CNS is undoubtedly complex and hampered by the relative Iack of MHC [2] and adhesion molecule expression (such as ICAM-1, [3] ) in this tissue. Nevertheless, the immune system under normal circumstances apparently copes with the vast majority ofviral infections in the CNS (reviewed in [4] ).
How is this effective immune surveillance achieved? First, it is possible that antigenic peptide is displayed on the Iumina) face of brain vascular endothelial cells. These cells [I 9710) Second, there is now good evidence to suggest that the brain is patrolled by activated T cells nonspecifically crossing the blood-brain barrier [6, 7] . However, Tcell recognition of viral peptides in the context of MHC dass I or dass li molecules is unlikely to occur readily in the parenchyma of the CNS. This is an important caveat as it is cells such as astrocytes, oligodendrocytes and neurons that are the foci of virus infection in subacute sclerosing panencephalitis for example [1] . Much attention has been focused on the ability of certain inflammatory cytokines, in particular IFN-y and TNF-a, to induce and up-regulate MHC and ICAM-1 expression on glial cells [7, 8] but the presence of these factors in the CNS would indicate that an inflammatory process has already been initiated. In the absence of such inflammation, which is a far more Jikely situation early after the virus has entered the CNS, inflammatory cytokine-mediated up-regulation of MHC and JCAM-1 expression on glial cells cannot be considered a viable mechanism for induction of conditions that would enable the infected cell to be recognized by T lymphocytes.
For virus infections of the CNS, one possibility is that the virus itself directly or indirectly induces or enhances the expression of cell-surface molecules important for T cell recognition. A number of reports have already been made regarding the up-regulation of MHC dass I on a variety of infected cell types ( [9] [10] [11] [12] , reviewed in [13] ) and also MHC class II induction on otherwise negative cells, including astrocytes [11, 12, 14] . The mechanisms underlying the alteration of MHC expression in virus-infected cells are unclear. In the present study we have examined the augmentation of MHC antigens and the adhesion molecule ICAM-1 on mixed glial cells infected in vitro with MV. The results clearly indicate that virus infection alone is sufficient to consistently increase astrocyte MHC class I and ICAM-1 expression and that these phenotypic changes are probably mediated by MV-induced release of type-1 IFN.
Materials and methods

Animals
Full-term pregnant rats and 8-to 10-week-old female rats were obtained from Zentralinstitut für Versuchstierzucht, Hannover, FRG. All animals were SPF and from the Lewis (LEW, RT1 1 ) and BDII {RT1 u) strains.
Monoclonal and polyclonal antibodies
Mouse mAb were: MRC OX1 (anti-rat CD45; leukocyte common antigen, [15] ), MRC OX6 (anti-rat monomorphic MHC dass II, RT1B (1-A), [16] ), MRC OX18 {anti-rat monomorphic MHC class I, RT1A, [17] ), MRC OX21 (anti-human C3bi and not rat cells, [18] ), MRC OX42 (anti-rat CDllb/c, [19, 20] ),WT.1 (anti-rat CDlla, LFA-1, [20] ), 1A29 (anti-rat CD54, ICAM-1, [21] ), mGalC (antigalactocerebroside, [22] ) and F227 (anti-MV nucleocapsid (N) protein, generated by Uwe Liebert of this Institute). MRC OX21 and F227 tissue culture SN were provided by Don Mason, Oxford, GB and by Uwe Liebert, respectively. All other mAb were prepared as tissue culture SN or ascites fluid from hybridomas obtained from Alan Williams, Oxford, GB (OX1,-6,-18,-42) and B. Ranscht (mGalc). MRC OX6, MRC OX18, 1A29 and WT.1 IgG were purified from ascites fluid by standard procedures. MRC OX6 and MRC OX18 IgG were biotinylated as described [23] . Rahbit anti-glial fibrillary acidic protein (GFAP) was from Dakopatts (Hamburg, FRG) and normal rabbit IgG from Dianova (Hamburg, FRG). AP5 (rabbit anti-mouse Mx protein that strongly binds rat Mx-1, [24] ) was kindly provided by Dr. Otto Haller, Institute for Virology, Freiburg, FRG. FITC-conjugated rat anti-mouse IgG, TRITCconjugated goat anti-rabbit IgG, PE-conjugated donkey F(ab') 2 anti-rabbit IgG (pre-absorbed against mouse and rat Ig) and PE-conjugated streptavidin were from Dianova.
Ceß lines, cytokines and miscellaneous reagents
Mycoplasma-free African green monkey kidney fibroblast (CV1) cells were obtained from the European Collection of Animal Cell Cultures, Porton Down, GB. A GFAP-isolate of the human glioma (D-54) cellline [25] [26] and MRC OX42 [19, 26] expression), were prepared from the meninges-stripped cerebrallobes of 1-to 2-day-old Lewis strain rats as described [27] . Cells were harvested from flasks and either seeded into wells of 6-well plates, directly stained for FCM or seeded into wells of 24-well plates containing glass coverslips to enable fluorescence microscopic analysis. Mixed glial cultures were prepared as above but were seeded at high density (usually around eight times that used to prepare enriched astrocyte cultures) directly into wells of 6-well or 24-well plates and were used within 10 days of culture establishment. The major cell types constituting these latter cultures are described in Sect. 3. Forvirus infection, medium was replaced with 1 ml (6-well plates) or 100 ~~ {24-well plates) mockinfected CV1 SN or MV at a concentration of 3 x 10 6 -5 X 10 6 PFU/ml ( corresponding to a multiplicity of infection of between 1 and 3) for 1 hat 37 °C, then the SN were removed and fresh medium was added. This is designated day 0. In most experiments, virus or mock SN were added as above to these same cell cultures 24 h later and again 48 h later. After a further 24 h, the cells were usually harvested for flow cytofluorographic analysis or coverslips stained for fluorescence microscopic analysis. rTNF-a, riFN-y or type-I IFN at a final concentration of 10 U/ml were added to glial cell cultures alone or together with mock or virus-containing supernatants (rTNF-a only) as detailed in Sect. 3. 
7 CTL assays
Alloreactive BDII CTL against LEW were generated in an MLR by mixing and incubation for 5 days 2. 3 Results
lotemal labeling of astrocytes
The cytoskeletal protein, GFAP, is the most reliable marker for astrocytes bothin vivo and in vitro [29] but because this is an intracellular molecule, detection requires permeabilization of the cell membrane. The protocol used here offers a number of advantages over other standard fixation/permeabilization procedures. Fig. 1 b illustrates the low Ievel of nonspecific staining by normal rabbit lgG (control), while addition of anti-GFAP produced a strong positive shift in around 90% of the cells. A comparable figure for GFAP+ cells in this population was obtained by standard immunofluorescence microscopy. Untreated astrocyte.s ( Fig. 1 a) were not stained with anti-GFAP. Other procedures tested, including paraformaldehyde fixation and permeabilization with Triton X-100, were unsatisfactory. The same scatter shift ( Fig. 1 b) was seen after 0.5% formalin fixation alone (not shown).
Astrocyte detection in cell mixtures
To study the effects of MV infection on glial cell expression of MHC and adhesion molccules in vitro, mixed glial populations were generally used rather than enriched astrocytes to more closely mirnie the in vivo situation.
forward scatter fluorescence Cells were cultured in the presence of FCS and so, as expected [29] , cell differentiation was driven in the direction of astrocytes. Astrocytes in situ are MHC dass I-or express extremely low Ievels of this molecule [2] but become MHC dass J+ during cell culture [30] . The GFAP+ cells shown in Fig. 2 c split into MHC dass J+ (around 50%) and class I-(around 20%) populations. lt is likely that the MHC dass I-GFAP+ cells are the more recently differentiated ones. The MHC dass I+ GFAP-cells (around 25%) are mostly M<I>/microglia (15-18%) which are CD45+ ( Fig. 2 d and e) and CDllbfc+ (Fig. 2 f) . There are two populations that remain undcfined. Around 5% of the cells are both MHC dass I-and GFAP- (Fig. 2 c, box 3 ). There are also some cells that are MHC dass J+ (Fig. 2 c, box 4) but arenot M<I>/microglia, at least as defined by CD45 and CDllb/c staining. Some of these cells could be oligodendrocytes but generally, < 5% galactocerebroside-positive cells (oligodendrocytes) were detected in these cultures.
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MV infection augments expression of MHC class I and ICAM-1 on astrocytes
Within 4 h ofvirus addition on day 0 to mixed glial cultures, the majority of cells were infected, as determined by immunofluorescence microscopic detection of cytoplasmic viral nucleocapsid protein. By 24 h, generally < 10% of the cells were infected by this same criterion and on the basis of cell morphology, the majority of these were astrocytes. In view of previous sturlies from this laboratory on the ability of both infectious and non-infectious viral partides to induce or enhance MHC expression on glial cells in vitro (11] , live virus was usually added on day 1 and day 2 although this did not result in an increase in the number of productively infected cells.
Double staining of infected cultures showed that MHC class I expression was significantly enhanced in both GFAP+ (astrocyte, into four populations almost identical to that seen with MHC dass 1/GFAP ( Fig. 2c ; see also Fig. 4 for ICAM-1 expression). Unlike MHC dass I, however, MV infection only resulted in increased expression of ICAM-1 on astrocytes. Mean fluorescence intensity shifts for ICAM-1 afterinfection in one experiment were: GFAP+ cells, 311 to 465 and GFAP-(microglial) cells, 462 to 490. In some cases the latter cell population did not shift at all. Thus, the data in Table 2 show only the changes in phenotype of astrocytes present within these mixed gliaJ cultures. Enhanced MHC dass I expression occurs rapidly, being evident by day 1 and normally peaking on day 2. The magnitude of ICAM-1 augmentation after MV infection is not as substantial, increases are not seen until day 2 and, like MHC dass I, ICAM-1 expression begins to reduce by day 3.
MHC dass II expression on > 15% of astrocytes was detected only in a minority of cases and more typical results are given in Table 2 and its legend. Addition of TNF-a together with virus did not further increase the expression ofMHCclass I, MHCclass II or ICAM-1 (data not shown). Note that addition of low Ievels of IFN-y to our mixed glial cultures (10 U/ml or less) induced high Ievel expression of MHC dass II on both astrocytes and microglia ( data not shown).
Expression of the intranuclear rat Mx protein and secretion of type-1 IFN
The possible re]ease of type-I IFN by infected glial cells was investigated employing antibody recognizing rat Mx, a protein inducible by type-I IFN but not IFN-y [24, 31] . Fig. 3 and Table 3 show that Mx was induced in a high proportion of cells in mixed glial cultures after virus infection. In araund 30% of infected cells, Mx was not detected but was highly induced in the surrounding cells (Fig. 3 a) . The remaining infected cells were also Mx+. Two additional points should be noted. First, transfer of SN cultures which is not surprising given previous studies [32] which found only very low Ievels (0.01-0.001 PFU/infected ceJl) of infectious virus present in glial cell SN obtained 24-48 h post MV infection. Second, treatment of mixed glial cultures with 10 U/ml rat type-1 IFN induced a comparable increase in MHC class I and ICAM-1 expression on astrocytes but had no effect on MHC dass II expression. Moreover, as illustrated in Fig. 4 , the cell populations responding to type-I IFN were similar to those that responded after virus infection as discussed above. Thus, type-I IFN increased MHC class I expression on aB cells in culture including M<l>/microglial cells (compare Fig. 4 a with 4 c where all populations shift to the right). In contrast, only "mature" GFAP+ ICAM-1 + cells (Fig. 4 b and 4d, box 2) revealed an increased ICAM-1 expression and the magnitude of this increase was relatively low as seen also after MV infection ( Table 2 To examine the functional impact of enhanced MHC class I and ICAM-1 Ievels on astrocytes, alloreactive CTL were generated and their ability to lyse enriched astrocytes derived from mock vs. infected cultures examined. The data shown in Fig·. 5 a (Exp. 1) is a typical outcome demonstrating that at lower E/T ratios, astrocytes from infected cultures were still lysed while those from mock-infected cultures were not. CTL activity was substantially reduced in the presence of 10 j..tg/ml mAb specific for MHC dass I and LFA-1 but not with this concentration of mAb against MHC dass II or ICAM -1 (Fig. 5 b) . The inability of the 1A29 mAb against rat ICAM-1 to block CfL activity was unexpected in view of the fact that this concentration of mAb prevents cell-cell adhesion in vitro [21] . In a subsequent experiment to test whether this was due to a concentration effect (Exp. 2), a variation on the enhanced killing of virus-infected astrocytes was observed. Percent specific releasewas very high and there was enhancement of killing compared with mock-infected astrocytes at both high and lower E/T ratios (Fig. 5 c) . The important aspect, however, was that doubling the concentration of anti-ICAM-1 mAb to 20 j..tg/ml resulted in effective CfL inhibition, whereas 20 j..tg/ml anti-MHC class li mAb still had no effect (Fig. 5 d) . CfL specificity was tested aginst T cell blasts. Typical specific 51 Cr release at a 1 : 50 ratio for syngeneic BDII blasts was < 1% and for allogeneic LEW blasts, around 40%.
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Discussion
Increasing the expression Ievels of cell-surface molecules that are essential for T cell recognition of virus-infected cells is obviously a critical step in the development of effective antiviral immune responses in the CNS. As demonstrated here and elsewhere for MHC molecules [10] [11] [12] 14] and for the firsttime for ICAM-1 (Table 2) , it is apparent that enhanced expression may result from the virus infection itself, rather than in response to inflammatory cytokines. It is apparent moreover, that this has a functional impact in as much as an increased susceptibility Eur. J. Immunol. 1992. 22: 175-182 of astrocytes from infected cultures to MHC dass 1-restricted CTL was consistently observed (Fig. 5 ). Yet the mechanisms by which cell surface molecule expression may be induced or augmented in situations such as that seen here, are not weil understood.
There are at least three ways in which virus infection may influence the expression of cell surface molecules: ( a) direct effect of the virus. Possibilities here include a virus transactivating gene product that influences cellular genes contro1ling expression of surface antigens [33, 34] ; (b) virus-induced release of factors such as type-I IFN that act in an autocrine fashion onto the producing cell and (c) as per mechanism 2 but also acting on other cells (13] . With regard to the MV-mediated MHC and ICAM-1 enhancement observed here, there is as yet no evidence for the existence of a MV transactivating capacity. However, certain IFN-inducible genes have been shown tobe induced directly by double-stranded RNA [35] or intact virus [36] . This raises the possibility that RNA viruses like MV may directly up-regulate the expression of surface molecules such as MHC dass I in a similar way, particularly as there is significant sequence homology between the promoter regions of MHC dass I and type-I IFN genes [37] . To date, however, no direct evidence is available that such a mechanism is operating here.
We believe that the presence of Mx in cultures infected with MV is a good indicator for the presence of type-I IFN and indeed, the SN transfer studies confirm that IFN bad been secreted. Moreover, this same cytokine when added to glial cultures was capable of modifying MHC dass I and ICAM-1 expression (Fig. 4) in a comparable manner. Thus, it is likely that type-1 IFN is playing a centrat roJe in these experiments. Nevertheless, it is difficult to prove this mechanism unequivocally. As noted in Sect. 3, studies with blocking anti-IFN antibody did not effectively prevent MV-induced augmentation of surface molecule expression. On the one hand, this preliminary result could suggest that IFN is not involved and that MHC class I and ICAM-1 enhancement, and even Mx induction, are directly mediated by virus via mechanisms akin to those discussed above. However, there are major limitations to these (Fig. 3) .
Release of type-1 IFN by virus-infected ce11s does not readily explain the low Ievel induction of MHC dass Il on astrocytes observed in some of our experiments and in studies by others [11, 12, 14] . Neutralizing antiborlies have been used [11] to exclude the role of IFN-y in virusmediated induction of MHC dass II although, as with the present studies with anti-type-1 IFN antibodies, such an approach cannot entirely exclude autocrine effects. Nevertheless, it is most unlikely that IFN-y could be responsible because typical cellular sources of IFN-y such as T lymphocytes and NK cells are absent and there is no evidence that astrocytes (or microglia) produce it. Moreover, addition of IFN-y to mixed glial cultures induced MHC dass II expression on both astrocytes and microglia, while after MV infection, only the former cell type became MHC dass n+ at a very low Ievel. It is notable that the Ievels of MHC dass II induction were less than that observed previously with MV in a similar system [11] . This may be explained by the high Ievels of type-I IFN in our cultures as this cytokine is reported to inhibit MHC dass II induction [38) .
Opinions are divided concerning the relative importancc of cytolytic CD4+ [39] or CD8+ (40] T Iymphocytes in the immunological control of MV infection. lt is now dear that peptides derived from internal MV structural proteins can be presented by both MHC dass I [41] and MHC dass II molecules [42] and MV appears relatively unusual, although not uniquc [43) in this respect. In rat models of CNS MV infection, there is evidence for a centrat role for both cytolytic CD8+ (44] as weil as CD4+ [45) Tcells in control of infection. Nevertheless, with regard to elimination of CNS-associated virus, it would appear from the present studies that MHC dass I is more likely to be enhanced on infected glial cells and in that sense, MHC · dass 1-restricted CTL should more readily be able to recognize the infected target cell. Furthermore, in general, it is difficult to induce MHC dass II in vivo on the typical target cells of MV in the CNS, such as astrocytes, neurons and oligodendrocytes although it is certainly possible that the low Ievels that are induced are sufficient to allow CD4 + T cell recognition. Received J uly 1, 1991; in final revised form September 5, 1991.
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